Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$191.51 - $216.16 $6.81 Million - $7.69 Million
-35,557 Reduced 24.72%
108,286 $22.9 Million
Q2 2023

Jul 25, 2023

BUY
$187.64 - $206.25 $1.46 Million - $1.6 Million
7,758 Added 5.7%
143,843 $27.5 Million
Q1 2023

Apr 24, 2023

SELL
$127.59 - $203.08 $4.9 Million - $7.81 Million
-38,442 Reduced 22.03%
136,085 $27.4 Million
Q4 2022

Feb 01, 2023

BUY
$117.37 - $139.17 $1.65 Million - $1.95 Million
14,033 Added 8.74%
174,527 $21.9 Million
Q3 2022

Nov 02, 2022

BUY
$135.27 - $180.11 $3.1 Million - $4.12 Million
22,884 Added 16.63%
160,494 $21.7 Million
Q2 2022

Aug 03, 2022

SELL
$108.81 - $179.33 $7,507 - $12,373
-69 Reduced 0.05%
137,610 $24.2 Million
Q1 2022

Apr 28, 2022

BUY
$119.61 - $157.85 $3.05 Million - $4.02 Million
25,461 Added 22.69%
137,679 $19.9 Million
Q4 2021

Feb 02, 2022

BUY
$142.57 - $190.86 $330,762 - $442,795
2,320 Added 2.11%
112,218 $17.5 Million
Q3 2021

Oct 22, 2021

SELL
$142.45 - $169.82 $146,865 - $175,084
-1,031 Reduced 0.93%
109,898 $18 Million
Q2 2021

Aug 05, 2021

SELL
$135.08 - $161.1 $94,961 - $113,253
-703 Reduced 0.63%
110,929 $17.5 Million
Q1 2021

Apr 28, 2021

BUY
$137.51 - $190.8 $2.89 Million - $4 Million
20,984 Added 23.15%
111,632 $15.3 Million
Q4 2020

Mar 12, 2021

BUY
$164.63 - $211.93 $14.9 Million - $19.2 Million
90,648 New
90,648 $16.8 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.